IlluminOss Medical Announces the Successful Treatment of First U.S. Patients With Innovative Light-Curable Bone Stabilization System (press release)
Dr. Felix Cheung and Team from Marshall University Utilize World’s First Minimally Invasive, Patient-Conforming Implant to Treat Impending Humerus Fractures
East Providence, RI (June 23, 2015) – IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopaedic fracture repair, today announced that the first two U.S. patients have been treated through Marshall University Joan C. Edwards School of Medicine in collaboration with Cabell-Huntington Hospital and the Marshall Clinical Research Center as part of its U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures in the humerus due to metastatic carcinoma.
The surgeries were performed by Felix Cheung, MD, associate professor and chief of the Division of Orthopaedic Oncology. Dr. Cheung is a board certified orthopaedic surgeon specializing in tumors of the musculoskeletal system and joint replacement surgery.
Gene DiPoto, senior vice president of R&D at IlluminOss Medical, worked closely with Dr. Cheung and his team ...
